BioCardia Inc. (BCDA)
NASDAQ: BCDA
· Real-Time Price · USD
2.14
-0.09 (-4.04%)
At close: Jun 27, 2025, 3:59 PM
2.15
0.47%
After-hours: Jun 27, 2025, 04:01 PM EDT
-4.04% (1D)
| Bid | 2.01 |
| Market Cap | 11.08M |
| Revenue (ttm) | -55K |
| Net Income (ttm) | -8.39M |
| EPS (ttm) | -2.14 |
| PE Ratio (ttm) | -1 |
| Forward PE | -2.26 |
| Analyst | Buy |
| Ask | 2.26 |
| Volume | 26,326 |
| Avg. Volume (20D) | 88,714 |
| Open | 2.16 |
| Previous Close | 2.23 |
| Day's Range | 2.11 - 2.16 |
| 52-Week Range | 1.63 - 4.66 |
| Beta | 0.84 |
About BCDA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BCDA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BCDA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-16.25%
BioCardia shares are trading lower after the compa...
Unlock content with
Pro Subscription
5 months ago
+3.65%
BioCardia shares are trading higher after the company announced that the American College of Cardiology 2025 Scientific Sessions accepted the presentation for the results of the double-blind randomized placebo-controlled CardiAMP HF Phase 3 study.
